Drugmaker group boosts lobbying as Trump’s push to lower prices stalls
The Pharmaceutical Research and Manufacturers of America, which represents leading drugmakers including Eli Lilly and Co., reported spending $6.2 million in the quarter. Meanwhile, Lilly boosted its own spending on lobbying.